Your browser doesn't support javascript.
loading
Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
Gomez-Larrauri, Ana; Das Adhikari, Upasana; Aramburu-Nuñez, Marta; Custodia, Antía; Ouro, Alberto.
Afiliação
  • Gomez-Larrauri A; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country, P.O. Box 644, 48980 Bilbao, Spain.
  • Das Adhikari U; Respiratory Department, Cruces University Hospital, P.O. Box 644, 48903 Barakaldo, Spain.
  • Aramburu-Nuñez M; Ragon Institute of MGH, MITHarvard and HarvardMIT, Cambridge, MA 02139, USA.
  • Custodia A; Harvard Medical School, Boston, MA 02114, USA.
  • Ouro A; Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela (IDIS), Travesa da Choupana s/n, 15706 Santiago de Compostela, Spain.
Medicina (Kaunas) ; 57(7)2021 Jul 19.
Article em En | MEDLINE | ID: mdl-34357010
ABSTRACT
Sphingolipids are both structural molecules that are essential for cell architecture and second messengers that are involved in numerous cell functions. Ceramide is the central hub of sphingolipid metabolism. In addition to being the precursor of complex sphingolipids, ceramides induce cell cycle arrest and promote cell death and inflammation. At least some of the enzymes involved in the regulation of sphingolipid metabolism are altered in carcinogenesis, and some are targets for anticancer drugs. A number of scientific reports have shown how alterations in sphingolipid pools can affect cell proliferation, survival and migration. Determination of sphingolipid levels and the regulation of the enzymes that are implicated in their metabolism is a key factor for developing novel therapeutic strategies or improving conventional therapies. The present review highlights the importance of bioactive sphingolipids and their regulatory enzymes as targets for therapeutic interventions with especial emphasis in carcinogenesis and cancer dissemination.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article